Terms: = Breast cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
71 results:
1. Clinical relevance of glycosylation in triple negative breast cancer: a review.
Chakraborty M; Kaur J; Gunjan ; Kathpalia M; Kaur N
Glycoconj J; 2024 Apr; 41(2):79-91. PubMed ID: 38634956
[TBL] [Abstract] [Full Text] [Related]
2. Suppression of AGRN enhances CD8+ T cell recruitment and inhibits breast cancer progression.
Tao J; Shen L; Zhuang M; Zhai C; Zeng H; Mao Y; Liu X
FASEB J; 2024 Apr; 38(7):e23582. PubMed ID: 38568853
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
[No Abstract] [Full Text] [Related]
4. Merkel Cell Carcinoma of Unknown Primary Origin.
Francetić H; Simetić L; Tomasović Lončarić Č; Štulhofer Buzina D; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(3):153-155. PubMed ID: 38439727
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Triple Negative breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
6. Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer.
Gao H; Ouyang D; Guan X; Xu J; Chen Q; Zeng L; Pang J; Zou Q; Qian K; Yi W
BMC Cancer; 2024 Jan; 24(1):50. PubMed ID: 38195475
[TBL] [Abstract] [Full Text] [Related]
7. Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancer.
Lin L; Li H; Wang X; Wang Z; Su G; Zhou J; Sun S; Ma X; Chen Y; You C; Gu Y
Cancer Med; 2023 Dec; 12(24):21639-21650. PubMed ID: 38059408
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Blansky D; Ansari N; Gao L; Sokol ES; Sivakumar S; Huang RSP; Pelletier M; Levy M; Pavlick D; Danziger N; Ross JS; Lustberg M; Rozenblit M
Breast Cancer Res Treat; 2024 Feb; 204(1):181-185. PubMed ID: 37999916
[TBL] [Abstract] [Full Text] [Related]
9. Using anti-pd-l1 antibody conjugated gold nanoshelled poly (Lactic-co-glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer.
Jiang H; Zhou Y; Zheng D; Cheng Y; Xiang D; Jiang L; Du J
J Biomed Mater Res A; 2024 Mar; 112(3):402-420. PubMed ID: 37941485
[TBL] [Abstract] [Full Text] [Related]
10. Enzyme-catalyzed electrochemical aptasensor for ultrasensitive detection of soluble pd-l1 in breast cancer based on decorated covalent organic frameworks and carbon nanotubes.
Zhang Y; Chen S; Ma J; Zhou X; Sun X; Jing H; Lin M; Zhou C
Anal Chim Acta; 2023 Nov; 1282():341927. PubMed ID: 37923412
[TBL] [Abstract] [Full Text] [Related]
11. In Situ Simultaneous Detection of Surface Protein and microRNA in Clustered Extracellular Vesicles from cancer Cell Lines Using Flow Cytometry.
Lee JY; Lee S; Lee H; Tran TTP; Kim BC; Rhee WJ
ACS Biomater Sci Eng; 2023 Nov; 9(11):6369-6378. PubMed ID: 37905510
[TBL] [Abstract] [Full Text] [Related]
12. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
Peng J; Li P; Li Y; Quan J; Yao Y; Duan J; Liu X; Li H; Yuan D; Wang X
Sci Rep; 2023 Oct; 13(1):17399. PubMed ID: 37833332
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic biopsy does not accurately reflect the pd-l1 expression in triple-negative breast cancer.
Zdrenka M; Kowalewski A; Borowczak J; Łysik-Miśkurka J; Andrusewicz H; Nowikiewicz T; Szylberg Ł
Clin Exp Med; 2023 Dec; 23(8):5121-5127. PubMed ID: 37804360
[TBL] [Abstract] [Full Text] [Related]
14. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
15. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.
Ohashi A; Kataoka M; Iima M; Honda M; Ota R; Urushibata Y; Dominik Nickel M; Toi M; Zackrisson S; Nakamoto Y
Eur Radiol; 2023 Nov; 33(11):8132-8141. PubMed ID: 37286791
[TBL] [Abstract] [Full Text] [Related]
16. Immunotherapy in Early-Stage Triple-Negative breast cancer: Where Are We Now and Where Are We Headed?
Dixon-Douglas J; Loi S
Curr Treat Options Oncol; 2023 Aug; 24(8):1004-1020. PubMed ID: 37222922
[TBL] [Abstract] [Full Text] [Related]
17. Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: diagnosis, mechanism, and treatment strategies.
Guo X; Chen S; Wang X; Liu X
Front Immunol; 2023; 14():1138483. PubMed ID: 37081866
[TBL] [Abstract] [Full Text] [Related]
18. Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.
Nahas GR; Sherman LS; Sinha G; El Far MH; Petryna A; Munoz SM; Silverio KA; Shaker M; Neopane P; Mariotti V; Rameshwar P
Aging (Albany NY); 2023 Mar; 15(9):3230-3248. PubMed ID: 36996499
[TBL] [Abstract] [Full Text] [Related]
19. Accurate and rapid quantification of pd-l1 positive exosomes by a triple-helix molecular probe.
Fan Z; Weng Q; Li Y; Zeng T; Wang J; Zhang H; Yu H; Dong Y; Zhao X; Li J
Anal Chim Acta; 2023 Apr; 1251():340984. PubMed ID: 36925282
[TBL] [Abstract] [Full Text] [Related]
20. The molecular landscape of breast mucoepidermoid carcinoma.
Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
[TBL] [Abstract] [Full Text] [Related]
[Next]
